Affiliation: University of Bologna
De Giovanni C, Landuzzi L, Palladini A, Ianzano M, Nicoletti G, Ruzzi F, et al
. Cancer Vaccines Co-Targeting HER2/Neu and IGF1R. Cancers (Basel). 2019;11: pubmed publisher
..Cell vaccines co-targeting HER2/neu and IGF1R elicited low levels of specific antibodies that slightly delayed onset of HER2/neu-driven, IGF1R-dependent tumors. ..
Croci S, Nanni P, Palladini A, Nicoletti G, Grosso V, Benegiamo G, et al
. Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis. Breast Cancer Res. 2015;17:70 pubmed publisher
Riccardo F, Arigoni M, Buson G, Zago E, Iezzi M, Longo D, et al
. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. BMC Genomics. 2014;15 Suppl 3:S1 pubmed publisher
..Our study provided a complete transcription overview of the K-ras(LA1)/p53(R172H?g) mouse NSCLC model. This approach allowed the detection of ADORA3 as a potential target for antibody-based therapy in p53 mutated tumors. ..
Pennisi M, Pappalardo F, Palladini A, Nicoletti G, Nanni P, Lollini P, et al
. Modeling the competition between lung metastases and the immune system using agents. BMC Bioinformatics. 2010;11 Suppl 7:S13 pubmed publisher
..These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model. ..